DeuteRx
No bio yet
This person is not in the org chart
This person is not in any teams
This person is not in any offices
DeuteRx
Formed in 2012, DeuteRx is a virtual biopharmaceutical company focused on improving racemic drugs for patients. The team has pioneered the use of Deuterium-Enabled Chiral Switching (DECS) to isolate a single stereoisomer from a mixture of interconverting stereoisomers.